Postmarket Surveillance Reform Board Gets Injection Of Device Industry Experience
This article was originally published in The Gray Sheet
The appointments of three device industry veterans to the Brookings-administered, and partially FDA-funded, Planning Board is intended to expand the range of input in the next phase of development of a new National Medical Device Surveillance System.
You may also be interested in...
A new national evaluation system for devices will provide collective bargaining power to reduce the costs of real-world data to substitute for clinical trials in company submissions.
The public-private National Medical Device Evaluation System Planning Board, first convened in 2014, is seeking nominations for new members to support the next two-year phase of development of a revamped postmarket surveillance system.
The FDA-endorsed Medical Device Registry Task Force maps out a path toward "coordinated registry networks," starting with pilot projects and 11 prioritized device categories.